Welcome to TINNET: An Action for Better Understanding the Heterogeneity of Tinnitus to Improve and Develop New Treatments

TINNET Management Committee in Brussels, 19 January 2015

Antonio MD kleinA new paper about the diagnostic criteria of Menière's disease just appeared. The paper published by Lopez-Escamez et al. represents a consensus of several international societies, namely the AAO-HNS, EAONO, Barany Society, Japan Society for Equilibirum Research and Korean Balance Society [pdf].

EFAS2015On Friday 29 May, Deb Hall has been leading an invited session on Tinnitus as the 12th Congress of The European Federation of Audiology Societies (EFAS) in Istanbul. The session included invited talks that cover a range of topics including hidden hearing loss (Plack, UK), the Autifony Therapeutics drug pipeline (Large, Italy), sound-based therapies (Hall, UK) and EU research partnership TINNET (Haider, Portugal).  See http://efas2015.eu/ for more details.

The picture shows Deb Hall (left) and all other invited speakers, including TINNET member Haula Haider who presented an overview of the TINNET program.

Recently, a new article about the TINNET project appeared in Trends in Hearing: Hall et al. 2015: "Toward a Global Consensus on Outcome Measures for Clinical Trials in Tinnitus: Report From the First International Meeting of the COMiT Initiative, November 14, 2014, Amsterdam, The Netherlands". Trends Hear. 2015 Apr 24;19.

Ms. Agnieszka Szczepek, Berlin, Germany, performed her research activities at the National Institute for Health Research Nottingham Hearing Biomedical Research Unit, Nottingham (UK) in March 2015 for the Short Term Scientific Mission "Developing expertise in systematic review Methodology and strengthening European collaboration across TINNET".

STSM Report

WG 2 (Database/Subtyping) GP1 Meeting, Klagenfurt

On 29.-30. January 2014 the second WG2 "Database" Meeting in Klagenfurt, Austria.


Christopher CederrothWe congratulate Christopher Cederroth, co-chair of the the TINNET genetics working group, to his appointment as Assistant Professor at the Karolinska Institutet in Stockholm.

Thanks to his professional advancement his laboratory can now focus on the prevention and cure of tinnitus and hearing loss. His laboratory tackles the problem with a dual approach i) using animal models of hearing loss and tinnitus to decipher the molecular pathways disrupted in the ear and/or in the brain and ii) using genetics in homogenous sub-types of tinnitus patients, having in aim the identification and validation of new targets for drug development. For the latter purpose, he recently created STOP "Swedish Tinnitus Outreach Project" where he identified from local cohorts more than 30'000 individuals with chronic tinnitus on which he wishes to perform in-depth phenotypic characterization (questionnaire and audiological subtyping). This will lead to a valuable pool of homogenous patients for their genetic analysis.

More information on the personal webpage of Christopher Cederroth.

TINNET is a European research network funded from April 11, 2014 to April 10, 2018 by the COST program under the Action number BM1306.

TINNET on Facebook

Facebook TINNET Page